LBRX
LB Pharmaceuticals Inc19.82
-0.04-0.2%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
501.43MP/E (TTM)
-Basic EPS (TTM)
-0.74Dividend Yield
0%Recent Filings
8-K
8-K
10-Q
8-K
IPO governance updates filed
LB Pharmaceuticals Inc. amended and restated its certificate of incorporation and bylaws effective September 12, 2025, coinciding with its IPO closing. These updates, approved by the board and stockholders beforehand, align governance with public company standards. No specific financial impacts disclosed. Standard move for new listings.
CNBX
CNBX Pharmaceuticals Inc.
0.00+0.00
CYBN
Cybin Inc.
6.66+0.00
DRUG
Bright Minds Biosciences Inc.
93.99+8.32
FBRX
Forte Biosciences, Inc.
23.27+1.31
LENZ
LENZ Therapeutics, Inc.
16.70-0.38
LIXT
Lixte Biotechnology Holdings, I
4.10+0.11
LRMR
Larimar Therapeutics, Inc.
3.74-0.18
LXRX
Lexicon Pharmaceuticals, Inc.
1.20-0.03
NRXP
NRX Pharmaceuticals, Inc.
2.10+0.12
RVPH
Reviva Pharmaceuticals Holdings
0.64+0.01